Express Healthcare

Jaslok Hospital partners with Oncoshot India

0 308

Oncoshot is developing oncology clinical studies that will use the most modern oncology chemicals for the benefit of cancer patients

Jaslok Hospital and Research Centre has collaborated with Oncoshot India in an effort to increase awareness, transparency and accessibility for cancer clinical trials to the entire Indian cancer ecosystem. This collaboration will work towards the empowerment of the Indian cancer patient population with its unique offering of clinical trial matching services.

Oncoshot is developing oncology clinical studies that will use the most modern oncology chemicals for the benefit of cancer patients, carers, and families. Some of India’s best oncologists, including Dr. Suresh Advani, Dr. Boman Dhabhar, Dr. Tapan Saikia, and Dr. Ritu Jain, will head oncology clinical treatment at Jaslok Hospital.

Jitendra Haryan, CEO, Jaslok Hospital, mentioned “Cancer is currently the most prevalent aid that requires treatment. We believe that by adapting this technology, we will be advancing the care and belief of all cancer patients that they can be saved by this technology. We want better health for all of our patients, and we work hard daily to improve our technology so that when a patient comes to us, we can provide better treatment. However, there is a growing need among Indian oncologists to bring more cancer clinical trials to India. This includes raising awareness and boosting access to cancer clinical trials. We are happy to collaborate with Oncoshot to make this possible.”

Dr Nilesh Atre, Managing Director, Oncoshot India, “This partnership with Jaslok Hospital is of our best collaboration efforts so far, because it strengthens our strategic positioning to deliver our pioneering services to the cancer patients in the Mumbai Metropolitan Region, Indian national and international oncology ecosystems. Oncoshot India aims to empower the entire Indian cancer patient population with its pioneering technology solutions for matching cancer clinical trials. We are really grateful for all our key Indian partnerships, because of which we have been able to achieve our goals.”

 

- Advertisement -

Leave A Reply

Your email address will not be published.